Terragen Holdings Limited

TGH.ASX

Materials

Australian ag-biotech group whose core technology platform addresses animal health, animal nutrition, soil health and plant productivity without relying on chemical-based fertilisers, pesticides and antibiotics. Terragen develops, produces, and markets biological products for agriculture

Market Data

Price

$0.020

+0.1%
Market Cap

$16.5M

P/E Ratio

-100000.0x

EPS

$-0.006

Div. Yield

0.00%

52-Week Change

-0.1%

Latest Earnings

Appendix 4D and Half Year Financial Report - 31 Dec 2025

19 February 2026

Revenue
$0.67
-26.0% YoY
NPAT
-$1.78
+22.7% YoY
EPS
$-0.00
Dividend
$0.00

Terragen Holdings reported a half-year loss of $1.8M (23% improvement from $2.3M loss in prior year) with revenue declining 26% to $672K due to dry conditions in key Australian markets and strategic shift to R&D focus. The company successfully raised $7M in February 2026 to accelerate global commercialisation of its agricultural biological products. Key points: Net loss improved 23% to $1.8M compared to $2.3M in prior period; New product Terragen Probiotic for Ruminants showed strong growth with Q4 sales up 87% on Q3; Successful $7M equity raising in February 2026 to accelerate global commercialisation

Recent Announcements

8 Apr 2026 Sph Neutral

Ceasing to be a substantial holder

One Funds Management Limited ATF Saville Capital Emerging Companies ceased to be a substantial holder.

19 Feb 2026 Actual Results Neutral

Appendix 4D and Half Year Financial Report - 31 Dec 2025

Terragen Holdings reported a half-year loss of $1.8M (23% improvement from $2.3M loss in prior year) with revenue declining 26% to $672K due to dry conditions in key Australian markets and strategic shift to R&D focus. The company successfully raised $7M in February 2026 to accelerate global commercialisation of its agricultural biological products. Key points: Net loss improved 23% to $1.8M compared to $2.3M in prior period; New product Terragen Probiotic for Ruminants showed strong growth with Q4 sales up 87% on Q3; Successful $7M equity raising in February 2026 to accelerate global commercialisation

19 Feb 2026 Sph Neutral

Becoming a substantial holder

trustee of the Christopher Wallin Superannuation Fund No.2 trust (Captain Nominees) (and their associates) and became a substantial holder.

17 Feb 2026 Sph Neutral

Ceasing to be a substantial holder from TEK

TEK ceased to be a substantial holder.

Get real-time alerts for TGH

Receive AI-powered earnings summaries and instant notifications when Terragen Holdings Limited releases results.

Register Free